punicalagin   Click here for help

GtoPdb Ligand ID: 13430

Compound class: Natural product
Comment: Punicalagin is an 'ellagitannin' polyphenol compound that can be isolated from pomegranates and other Myrtales species plants. It has proposed anti-inflammatory action (inhibiting NF-κB) and anti-cancer potential [1,4-5,7,9-10]. Punicalagin can be hydrolysed to generate smaller phenolic compounds including ellagic acid.

SARS-CoV-2: Punicalagin has been reported as a an inhibitor of the helicase activity of coronavirus nsp13 [2,6].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 30
Hydrogen bond donors 17
Rotatable bonds 0
Topological polar surface area 510.94
Molecular weight 1084.72
XLogP 4.08
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES C1=C(C(=C(C2=C1C(=O)OC[C@@H]3[C@H]([C@H]4[C@H](C(O)O3)OC(=O)C5=C(C6=C(C=C(C(=C6O)O)O)C(=O)O4)C(=C(C(=C5)O)O)O)OC(=O)C7=C(C8=C9C%10=C(C(=C8O)O)OC(=O)C%11=C2C(=C(C(=C%10%11)OC9=O)O)O)C(=C(C(=C7)O)O)O)O)O)O
Isomeric SMILES C1[C@@H]2[C@H]([C@H]3[C@H](C(O2)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O3)O)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C8C9=C7C(=O)OC%10=C(C(=C(C%11=C(C(=C(C=C%11C(=O)O1)O)O)O)C(=C9%10)C(=O)O8)O)O)O)O)O)O)O
InChI InChI=1S/C48H28O30/c49-10-1-6-17(31(59)27(10)55)19-23-21-22-24(47(70)76-38(21)35(63)33(19)61)20(34(62)36(64)39(22)75-46(23)69)18-9(4-13(52)28(56)32(18)60)43(66)74-37-14(5-72-42(6)65)73-48(71)41-40(37)77-44(67)7-2-11(50)25(53)29(57)15(7)16-8(45(68)78-41)3-12(51)26(54)30(16)58/h1-4,14,37,40-41,48-64,71H,5H2/t14-,37-,40+,41-,48?/m1/s1
InChI Key ZJVUMAFASBFUBG-UYMKNUMKSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
References
1. Alsufiani HM. (2024)
The synergistic effect of oxaliplatin and punicalagin on colon cancer cells Caco-2 death.
Int J Health Sci (Qassim), 18 (2): 33-37. [PMID:38455601]
2. Bolinger AA, Li J, Xie X, Li H, Zhou J. (2024)
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.
Expert Opin Drug Discov, 19 (9): 1023-1041. [PMID:39078037]
3. Giamogante F, Marrocco I, Cervoni L, Eufemi M, Chichiarelli S, Altieri F. (2018)
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity.
Biochimie, 147: 122-129. [PMID:29425676]
4. Huang WC, Liou CJ, Shen SC, Hu S, Chao JC, Huang CH, Wu SJ. (2024)
Punicalagin from pomegranate ameliorates TNF-α/IFN-γ-induced inflammatory responses in HaCaT cells via regulation of SIRT1/STAT3 axis and Nrf2/HO-1 signaling pathway.
Int Immunopharmacol, 130: 111665. [PMID:38367463]
5. Illescas-Montes R, Rueda-Fernández M, González-Acedo A, Melguizo-Rodríguez L, García-Recio E, Ramos-Torrecillas J, García-Martínez O. (2023)
Effect of Punicalagin and Ellagic Acid on Human Fibroblasts In Vitro: A Preliminary Evaluation of Their Therapeutic Potential.
Nutrients, 16 (1). [PMID:38201853]
6. Inniss NL, Rzhetskaya M, Ling-Hu T, Lorenzo-Redondo R, Bachta KE, Satchell KJF, Hultquist JF. (2024)
Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
SLAS Discov, 29 (3): 100145. [PMID:38301954]
7. Li H, Ruan J, Huang J, Yang D, Yu H, Wu Y, Zhang Y, Wang T. (2023)
Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis.
Int J Mol Sci, 24 (24). [PMID:38139367]
8. Paglia G, Antonini L, Cervoni L, Ragno R, Sabatino M, Minacori M, Rubini E, Altieri F. (2021)
A Comparative Analysis of Punicalagin Interaction with PDIA1 and PDIA3 by Biochemical and Computational Approaches.
Biomedicines, 9 (11). [PMID:34829762]
9. Sun DP, Uen YH, Kang NW, Chang CC, Tian YF, Fang CL, Lin KY. (2024)
Punicalagin Restricts Growth, Promotes Apoptosis, and Reduces Invasion in Human Gastric Cancer Cells.
Dose Response, 22 (2): 15593258241264954. [PMID:38903205]
10. Zoofeen U, Shah M, Sultan S, Ehtesham E, Shah I, Sharif N, Khan M, Shah FA. (2024)
Punicalagin improves inflammation and oxidative stress in rat model of pelvic inflammatory disease.
Nat Prod Res,: 1-7 [Epub ahead of print]. [PMID:38329023]